DE69131979D1 - Genetisches igfbp-4 rodierendes material - Google Patents

Genetisches igfbp-4 rodierendes material

Info

Publication number
DE69131979D1
DE69131979D1 DE69131979T DE69131979T DE69131979D1 DE 69131979 D1 DE69131979 D1 DE 69131979D1 DE 69131979 T DE69131979 T DE 69131979T DE 69131979 T DE69131979 T DE 69131979T DE 69131979 D1 DE69131979 D1 DE 69131979D1
Authority
DE
Germany
Prior art keywords
protein
dna molecules
binding
igfbp
recombinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69131979T
Other languages
English (en)
Other versions
DE69131979T2 (de
Inventor
C Kiefer
Frank Masiarz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of DE69131979D1 publication Critical patent/DE69131979D1/de
Publication of DE69131979T2 publication Critical patent/DE69131979T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4743—Insulin-like growth factor binding protein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69131979T 1990-08-28 1991-08-28 Genetisches igfbp-4 rodierendes material Expired - Fee Related DE69131979T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57461390A 1990-08-28 1990-08-28
US07/576,629 US5212074A (en) 1990-08-28 1990-08-31 Genetic material encoding new insulin-like growth factor binding protein igfbp-6
PCT/US1991/006138 WO1992003469A1 (en) 1990-08-28 1991-08-28 Genetic material encoding igfbp-4

Publications (2)

Publication Number Publication Date
DE69131979D1 true DE69131979D1 (de) 2000-03-16
DE69131979T2 DE69131979T2 (de) 2000-10-05

Family

ID=27076435

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69131979T Expired - Fee Related DE69131979T2 (de) 1990-08-28 1991-08-28 Genetisches igfbp-4 rodierendes material

Country Status (9)

Country Link
US (1) US5212074A (de)
EP (1) EP0546053B1 (de)
JP (1) JPH06503709A (de)
AT (1) ATE189700T1 (de)
CA (1) CA2090704A1 (de)
DE (1) DE69131979T2 (de)
IE (1) IE913033A1 (de)
PT (1) PT98804B (de)
WO (1) WO1992003469A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004775A (en) * 1990-08-03 1999-12-21 The Salk Institute For Biological Studies DNA encoding IGFBP-4
US5401830A (en) * 1992-10-05 1995-03-28 The State University Of New Jersey Insulin receptor-like protein
AU686585B2 (en) 1992-11-04 1998-02-12 Dennis L Andress Truncated insulin-like growth factor binding proteins having mitogenic activity
US5710252A (en) * 1995-02-03 1998-01-20 Eastman Kodak Company Method for recombinant yeast expression and isolation of water-soluble collagen-type polypeptides
ES2224178T3 (es) 1995-10-11 2005-03-01 Chiron Corporation Cobinacion de pdgf, kgf,igf e igfbp para la cicatrizacion de heridas.
WO1997038003A1 (en) * 1996-04-11 1997-10-16 Human Genome Sciences, Inc. Human hematopoietic-specific protein
US5747273A (en) * 1996-05-07 1998-05-05 Diagnostic Systems Laboratories, Inc. Immunoassay of total insulin-like growth factor binding protein-1
US6841386B2 (en) 2001-04-10 2005-01-11 Viacell, Inc. Modulation of primary stem cell differentiation using an insulin-like growth factor binding protein
CA2498062C (en) * 2002-09-27 2010-05-25 F. Hoffmann-La Roche Ag Conjugates of insulin-like growth factor binding protein-4 and poly(ethylene glycol)
CA2541015A1 (en) * 2003-10-03 2005-04-14 Genentech, Inc. Igf binding proteins
US20070037186A1 (en) 2005-05-20 2007-02-15 Yuqiu Jiang Thyroid fine needle aspiration molecular assay
CN112877336B (zh) * 2021-03-05 2022-11-18 中国农业科学院农业基因组研究所 sfIMP-X1基因及其在草地贪夜蛾遗传防控中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK131988A (da) * 1988-03-11 1989-09-12 Erasmus University Igf-bindingsprotein, dna-struktur, der koder for igf-bindingsproteinet og vektor indeholdende denne dna-struktur
US5258287A (en) * 1988-03-22 1993-11-02 Genentech, Inc. DNA encoding and methods of production of insulin-like growth factor binding protein BP53
ATE132164T1 (de) * 1988-04-12 1996-01-15 Amgen Boulder Inc Verfahren zur steigerung und zur hemmung der wirkung eines insulinähnlichen wachstumfaktors
WO1990000569A1 (en) * 1988-07-15 1990-01-25 Central Sydney Area Health Service Acid-labile subunit (als) of insulin-like-growth factor (igf) binding protein complex
GB8826451D0 (en) * 1988-11-11 1988-12-14 Sandoz Ltd Improvements in/relating to organic compounds

Also Published As

Publication number Publication date
PT98804A (pt) 1992-08-31
DE69131979T2 (de) 2000-10-05
JPH06503709A (ja) 1994-04-28
ATE189700T1 (de) 2000-02-15
EP0546053A1 (de) 1993-06-16
WO1992003469A1 (en) 1992-03-05
US5212074A (en) 1993-05-18
IE913033A1 (en) 1992-03-11
CA2090704A1 (en) 1992-03-01
PT98804B (pt) 1999-01-29
EP0546053B1 (de) 2000-02-09
EP0546053A4 (en) 1994-08-17

Similar Documents

Publication Publication Date Title
ATE208816T1 (de) Neues insulinähnliches wachstumsfaktor bindendes protein igfbp-5
ATE208815T1 (de) Genetisches igfbp-5 rodierendes material
RU94045919A (ru) Антитела, клетки, полипептид, днк векторы, способ получения полипептида, способ получения антитела, фармацевтическая композиция
KR910700257A (ko) 상피 세포에 특이적인 성장인자를 암호하는 dna
PT93910A (pt) Prodesso para a preparacao de uma proteina heterologa mediante secrecao a partir de uma celula
DE10399010I1 (de) F}r Faktor-VIIIc kodierende DNA-Sequenzen und verwandte DNA-Konstruktionen
UA48105C2 (uk) ФРАГМЕНТ ДНК, ЯКИЙ КОДУЄ БІЛОК РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), РЕКОМБІНАНТНА МОЛЕКУЛА ДНК (ВАРІАНТИ), КЛІТИНА-ХАЗЯЇН (ВАРІАНТИ), СПОСІБ ОДЕРЖАННЯ БІЛКУ РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), БІЛОК РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ (ВАРІАНТИ), АНТИТІЛО АБО ФРАГМЕНТ АНТИТІЛА (ВАРІАНТИ), МОЛЕКУЛА КДНК (ВАРІАНТИ)
DE69131979D1 (de) Genetisches igfbp-4 rodierendes material
KR960704934A (ko) 항혈전활성을 갖는 펩티드 및 이의 제조방법(Peptide having antithrombotic activity and process for producing the same)
Ho et al. Purification and properties of a transcriptional activator. The cII protein of phage lambda.
DK95291D0 (da) Rekombinante dna-molekyler
Yamamura et al. High mobility group-like protein in bovine milk stimulates the proliferation of osteoblastic MC3T3-E1 cells
DE59109267D1 (de) Neue Signalsequenzen
ATE247164T1 (de) Insulinartigen wachstumsfaktor bindendes protein
KR870001311A (ko) 단백질 및 폴리펩티드의 제조 방법
CA2230111A1 (en) Antisecretory factor peptides regulating pathological permeability changes
ATE286069T1 (de) Verfahren zur herstellung rekombinanter pilc- proteine
RU2005123689A (ru) Флуоресцирующие белки из веслоногих ракообразных и способы их применения
SE9704141D0 (sv) New protein and nucleotide sequence, encoding said protein
WO1995008628A3 (en) Nucleic acids encoding merosin, merosin fragments and uses thereof
Wuyts et al. Purification and identification of human and mouse granulocyte chemotactic protein-2 isoforms
Bloemendal et al. Isolation of the intermediate filament protein vimentin by chromatofocusing
Goodman et al. Collagen preservation in soft tissue from the Magadan mammoth
Michiyo et al. Functional properties of the allotypes of mouse complement regulatory protein, factor H: difference of compatibility of each allotype with human factor I
DE50015410D1 (de) Nukleinsäuremolekül, umfassend eine für ein hämocyanin kodierende nukleinsäuresequenz und mindestens eine intronsequenz

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: NOVARTIS VACCINES AND DIAGNOSTICS,INC.(N.D.GES, US

8339 Ceased/non-payment of the annual fee